Being the focal point of our international operations, we manufacture and supply a wide-range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked amongst the fastest growing companies in terms of generic drugs sales.
Our other assets include Norac Pharma in California for API manufacturing and a finished dosage manufacturing facility in St Louis, Missouri for producing a complete range of formulations of controlled substances.
Our commitment to research has led us to cumulatively file over 144 ANDAs with the US FDA. Our products are available at major pharmacy chains, wholesalers, managed care companies, distributors and pharmaceutical retailers.
For more Information about Alkem's operations in the US, please visit http://www.ascendlaboratories.com